Brett Robinson

Brett Robinson has had a diverse range of work experiences throughout their career. Brett currently holds the position of Senior Scientist at Artizan Biosciences, Inc. since 2021.

Prior to their current role, from 2017 to 2019 they worked as a Research Scientist at Cybrexa Therapeutics, where they were responsible for conducting in vitro assays to validate a POC alphalex-PARP inhibitor. Brett also developed enzymatic assays for the analysis of warhead activity released by cleavage of peptide conjugated cancer therapeutics.

From 2010 to 2016, Brett worked at Kolltan Pharmaceuticals, Inc. as a Research Scientist in the field of Molecular Cell Biology and Immunology. In this role, they developed in vitro and in vivo assays to study the function of Tyro3, Axl, and MerTK receptors on innate immune cells. Brett also contributed to the structural characterization of these receptors and supported small molecule tyrosine kinase inhibitor discovery.

Before joining Kolltan Pharmaceuticals, Brett spent a significant portion of their career at Pfizer, starting in 2002. Brett held the position of Research Scientist in various areas, including Biologics and Osteoporosis/Healthy Aging. During this time, they were involved in target identification and validation in diabetes and osteoporosis, and conducted gene expression profiling and radioligand binding assays.

Brett began their career in 1994 at Bristol-Myers Squibb, where they worked as a Research Scientist. Brett contributed to antiviral programs, specifically in the areas of HIV-1 entry inhibitors and HCV replication studies.

Prior to their industry positions, Brett worked as a Research Associate at Targetech and as a Research Assistant at The University of Connecticut Health Center.

Overall, Brett Robinson has accumulated extensive experience in various research roles, with expertise in molecular cell biology, immunology, drug discovery, and target validation.

From 1985 to 1990, Brett Robinson attended the University of Connecticut. During this time, they pursued a degree in Microbiology, General and successfully completed their Bachelor of Science - BS.